NCT06772805View on ClinicalTrials.gov

A Study to Evaluate the Effect of Food on Nemtabrutinib (MK-1026) in Healthy Participants (MK-1026-016)

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

December 12, 2023

Study Completion Date

December 12, 2023

Conditions

Healthy

Interventions

DRUG

Nemtabrutinib

Oral Tablet

Trial Locations (1)

96813

Labcorp Clinical Research Unit Inc. (Site 0001), Honolulu

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY